Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Dager

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 19, 2010
Issues in assessing and reducing the risk for venous thromboembolismWilliam E Dager
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2007
Improving anticoagulation management in patients with atrial fibrillationWilliam E Dager
Seminars in Dialysis|August 2, 2011
Can enoxaparin be used safely in end-stage renal disease?William E Dager
The Annals of Pharmacotherapy|February 28, 2008
Considerations for drug dosing post coronary artery bypass graft surgeryWilliam E Dager
The Annals of Pharmacotherapy|December 13, 2025
Creating Solutions to the Challenges in Managing Heparin Infusions: Exploring Use of Technology Including Artificial Intelligence and the Role of Anticoagulation StewardshipWilliam E Dager
The Annals of Pharmacotherapy|May 17, 2002
Inventory control for advanced cardiac life support medicationsWilliam E Dager
The Annals of Pharmacotherapy|March 30, 2006
Aminoglycoside elimination in extended duration hemodialysisWilliam E Dager
The Annals of Pharmacotherapy|July 22, 2011
Using prothrombin complex concentrates to rapidly reverse oral anticoagulant effectsWilliam E Dager
The Annals of Pharmacotherapy|December 29, 2011
Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remainingWilliam E Dager
Seminars in Dialysis|November 12, 2010
What are the important drug use errors in dialysis patients? Pharmacokinetic and pharmacodynamic principlesWilliam E Dager
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 19, 2010
Issues in assessing and reducing the risk for venous thromboembolismWilliam E Dager
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 26, 2007
Improving anticoagulation management in patients with atrial fibrillationWilliam E Dager
Seminars in Dialysis|August 2, 2011
Can enoxaparin be used safely in end-stage renal disease?William E Dager
The Annals of Pharmacotherapy|February 28, 2008
Considerations for drug dosing post coronary artery bypass graft surgeryWilliam E Dager
The Annals of Pharmacotherapy|December 13, 2025
Creating Solutions to the Challenges in Managing Heparin Infusions: Exploring Use of Technology Including Artificial Intelligence and the Role of Anticoagulation StewardshipWilliam E Dager
The Annals of Pharmacotherapy|May 17, 2002
Inventory control for advanced cardiac life support medicationsWilliam E Dager
The Annals of Pharmacotherapy|March 30, 2006
Aminoglycoside elimination in extended duration hemodialysisWilliam E Dager
The Annals of Pharmacotherapy|July 22, 2011
Using prothrombin complex concentrates to rapidly reverse oral anticoagulant effectsWilliam E Dager
The Annals of Pharmacotherapy|December 29, 2011
Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remainingWilliam E Dager
Seminars in Dialysis|November 12, 2010
What are the important drug use errors in dialysis patients? Pharmacokinetic and pharmacodynamic principlesWilliam E Dager
Pageof 11